Cetuximab with irinotecan, folinic acid and 5-fluorouracil as first-line treatment in advanced gastroesophageal cancer: a prospective multi-center biomarker-oriented phase II study. [electronic resource]
Producer: 20111128Description: 1358-1366 p. digitalISSN:- 1569-8041
- Adult
- Aged
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Camptothecin -- administration & dosage
- Cetuximab
- Esophageal Neoplasms -- drug therapy
- Female
- Fluorouracil -- administration & dosage
- Humans
- Irinotecan
- Leucovorin -- administration & dosage
- Male
- Middle Aged
- Stomach Neoplasms -- drug therapy
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.